-
1
-
-
0029788990
-
Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90
-
Counsell CE, ColHe DA, Grant R. Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90. J Neurol Neurosurg Psychiatry 1996;61:143-50. (Pubitemid 26264323)
-
(1996)
Journal of Neurology Neurosurgery and Psychiatry
, vol.61
, Issue.2
, pp. 143-150
-
-
Counsell, C.E.1
Collie, D.A.2
Grant, R.3
-
2
-
-
34547122001
-
The 2007 WHO classification of tumours of the central nervous system
-
DOI 10.1007/s00401-007-0243-4
-
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO Classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109. (Pubitemid 47103521)
-
(2007)
Acta Neuropathologica
, vol.114
, Issue.2
, pp. 97-109
-
-
Louis, D.N.1
Ohgaki, H.2
Wiestler, O.D.3
Cavenee, W.K.4
Burger, P.C.5
Jouvet, A.6
Scheithauer, B.W.7
Kleihues, P.8
-
3
-
-
44649088238
-
Anaplastic oligodendroglial tumors: Refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402
-
DOI 10.1111/j.1750-3639.2008.00129.x
-
Giannini C, Burger PC, Berkey BA, Cairncross JG, Jenkins RB, Mehta M, et al. Anaplastic oligodendroglial tumors: re-fining the correlation among histopathology, 1p 19q dele-tion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol 2008;18:360-9. (Pubitemid 351782844)
-
(2008)
Brain Pathology
, vol.18
, Issue.3
, pp. 360-369
-
-
Giannini, C.1
Burger, P.C.2
Berkey, B.A.3
Cairncross, J.G.4
Jenkins, R.B.5
Mehta, M.6
Curran, W.J.7
Aldape, K.8
-
4
-
-
2442655049
-
Overview: Brain tumour diagnosis and manage-ment. Royal College of Physicians Guidelines
-
Grant R. Overview: brain tumour diagnosis and manage-ment. Royal College of Physicians Guidelines. J Neurol Neurosurg Psychiatry 2004;75:Suppl2: ii18-23.
-
(2004)
J Neurol Neurosurg Psychiatry
, vol.75
, Issue.SUPPL. 2
-
-
Grant, R.1
-
5
-
-
0036245455
-
1H-MRS) in the diagnosis and management of patients with brain tumors
-
DOI 10.1097/00001622-200205000-00007
-
Leclerc X, Huisman AGM, Sorensen AG. The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumors. Curr Opinion Oncol 2002;14:292-8. (Pubitemid 34492861)
-
(2002)
Current Opinion in Oncology
, vol.14
, Issue.3
, pp. 292-298
-
-
Leclerc, X.1
Huisman, T.A.G.M.2
Sorensen, A.G.3
-
6
-
-
12244252777
-
1H magnetic resonance spectroscopy
-
DOI 10.1002/mrm.10367
-
Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectro-scopy. Magn Res Med 2003;49:223-32. (Pubitemid 36159858)
-
(2003)
Magnetic Resonance in Medicine
, vol.49
, Issue.2
, pp. 223-232
-
-
Howe, F.A.1
Barton, S.J.2
Cudlip, S.A.3
Stubbs, M.4
Saunders, D.E.5
Murphy, M.6
Wilkins, P.7
Opstad, K.S.8
Doyle, V.L.9
McLean, M.A.10
Bell, B.A.11
Griffiths, J.R.12
-
7
-
-
0345254996
-
Glioma grading: Sensitivity, specificity, and predictive values of perfusion mr imaging and proton mr spectroscopic imaging compared with conventional MR imaging
-
Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectro-scopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989-98. (Pubitemid 37444849)
-
(2003)
American Journal of Neuroradiology
, vol.24
, Issue.10
, pp. 1989-1998
-
-
Law, M.1
Yang, S.2
Wang, H.3
Babb, J.S.4
Johnson, G.5
Cha, S.6
Knopp, E.A.7
Zagzag, D.8
-
8
-
-
42449135741
-
Low-grade gliomas: Do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
-
Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, et al. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 2008;247:170-8.
-
(2008)
Radiology
, vol.247
, pp. 170-178
-
-
Danchaivijitr, N.1
Waldman, A.D.2
Tozer, D.J.3
Benton, C.E.4
Brasil Caseiras, G.5
Tofts, P.S.6
-
9
-
-
44449133653
-
Gliomas: Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfu-sion MR imaging
-
Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfu-sion MR imaging. Radiology 2008;247:490-8.
-
(2008)
Radiology
, vol.247
, pp. 490-498
-
-
Law, M.1
Young, R.J.2
Babb, J.S.3
Peccerelli, N.4
Chheang, S.5
Gruber, M.L.6
-
10
-
-
33645986455
-
Fluorescence-guided surgery with 5-aminolaevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III study
-
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolaevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III study. Lancet Oncol 2006;7:392-401.
-
(2006)
Lancet Oncol
, vol.7
, pp. 392-401
-
-
Stummer, W.1
Pichlmeier, U.2
Meinel, T.3
Wiestler, O.D.4
Zanella, F.5
Reulen, H.J.6
-
11
-
-
20444404289
-
Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: A comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution
-
DOI 10.1136/jnnp.2004.048520
-
Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP,Van Effenterre R, et al. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a compara-tive study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 2005;76:845-51. (Pubitemid 40805817)
-
(2005)
Journal of Neurology, Neurosurgery and Psychiatry
, vol.76
, Issue.6
, pp. 845-851
-
-
Duffau, H.1
Lopes, M.2
Arthuis, F.3
Bitar, A.4
Sichez, J.-P.5
Van Effenterre, R.6
Capelle, L.7
-
12
-
-
33745575716
-
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group trial 9402
-
DOI 10.1200/JCO.2005.04.3414
-
Intergroup Radiation Therapy Oncology Group Trial 9402, Cairncross G, Berkey B, Shaw E, Jenkins R, et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligo-dendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 2006; 24: 2707-14. (Pubitemid 46630566)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.18
, pp. 2707-2714
-
-
Cairncross, G.1
Berkey, B.2
Shaw, E.3
Jenkins, R.4
Scheithauer, B.5
Brachman, D.6
Buckner, J.7
Fink, K.8
Souhami, L.9
Laperierre, N.10
Mehta, M.11
Curran, W.12
-
13
-
-
33745532038
-
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized European Organisation for Research and Treatment of Cancer phase III trial
-
DOI 10.1200/JCO.2005.04.6078
-
van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, et al. Adjuvant procarbazine, lomustine and vincristine improves progression-free survi-val but not overall survival in newly diagnosed anaplastic oligodendroglioma and oligoastrocytomas: a randomised European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 2006;24:2715-22. (Pubitemid 46630567)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.18
, pp. 2715-2722
-
-
Van Den Bent, M.J.1
Carpentier, A.F.2
Brandes, A.A.3
Sanson, M.4
Taphoorn, M.J.B.5
Bernsen, H.J.J.A.6
Frenay, M.7
Tijssen, C.C.8
Grisold, W.9
Sipos, L.10
Haaxma-Reiche, H.11
Kros, J.M.12
Van Kouwenhoven, M.C.M.13
Vecht, C.J.14
Allgeier, A.15
Lacombe, D.16
Gorlia, T.17
-
14
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
DOI 10.1056/NEJMoa043330
-
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96. (Pubitemid 40349501)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.B.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
Gorlia, T.14
Allgeier, A.15
Lacombe, D.16
Cairncross, J.G.17
Eisenhauer, E.18
Mirimanoff, R.O.19
-
15
-
-
33947191055
-
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
-
DOI 10.1158/1078-0432.CCR-06-2309
-
Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Dowell JM, Reardon DA, Quinn JA, et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 2007;13:1253-9. (Pubitemid 46424067)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.4
, pp. 1253-1259
-
-
Vredenburgh, J.J.1
Desjardins, A.2
Herndon II, J.E.3
Dowell, J.M.4
Reardon, D.A.5
Quinn, J.A.6
Rich, J.N.7
Sathornsumetee, S.8
Gururangan, S.9
Wagner, M.10
Bigner, D.D.11
Friedman, A.H.12
Friedman, H.S.13
-
16
-
-
41649112610
-
Bevacizumab for recurrent malignant gliomas
-
Norden AD, Young GS, Setayesh K, Muzikansky A, Klufas R, Ross GL, et al. Bevacizumab for recurrent malignant gliomas. Neurology 2008;70:779-87.
-
(2008)
Neurology
, vol.70
, pp. 779-787
-
-
Norden, A.D.1
Young, G.S.2
Setayesh, K.3
Muzikansky, A.4
Klufas, R.5
Ross, G.L.6
-
17
-
-
33846149645
-
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
-
DOI 10.1016/j.ccr.2006.11.021, PII S1535610806003709
-
Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007;11:83-95. (Pubitemid 46075199)
-
(2007)
Cancer Cell
, vol.11
, Issue.1
, pp. 83-95
-
-
Batchelor, T.T.1
Sorensen, A.G.2
Di Tomaso, E.3
Zhang, W.-T.4
Duda Dan, G.5
Cohen, K.S.6
Kozak, K.R.7
Cahill, D.P.8
Chen, P.-J.9
Zhu, M.10
Ancukiewicz, M.11
Mrugala, M.M.12
Plotkin, S.13
Drappatz, J.14
Louis, D.N.15
Ivy, P.16
Scadden, DavidT.17
Benner, T.18
Loeffler, J.S.19
Wen, P.Y.20
Jain, R.K.21
more..
-
18
-
-
55549085519
-
Response criteria for glioma
-
Sorensen AG, Batchelor TT, Wen PY, Zhang Wt, Jain RK. Response criteria for glioma. Nat Clin Pract Oncol 2008; 5:634-44.
-
(2008)
Nat Clin Pract Oncol
, vol.5
, pp. 634-644
-
-
Sorensen, A.G.1
Batchelor, T.T.2
Wen, P.Y.3
Wt, Z.4
Jain, R.K.5
-
19
-
-
0025281789
-
Response criteria for phase II studies of supratentorial malignant glioma
-
MacDonald DR, Cascino TL, Schold Sc Jr, Cairncross JG Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80. (Pubitemid 20195640)
-
(1990)
Journal of Clinical Oncology
, vol.8
, Issue.7
, pp. 1277-1280
-
-
Macdonald, D.R.1
Cascino, T.L.2
Schold Jr., S.C.3
Cairncross, J.G.4
-
20
-
-
20244364105
-
Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response
-
DOI 10.1073/pnas.0501532102
-
Moffat BA, Chenevert Tl, Lawrence TS, Meyer CR, Johnson TD, Dong Q, et al. Functional diffusion map: A non-invasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci 2005;102:5524-9. (Pubitemid 40530291)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.15
, pp. 5524-5529
-
-
Moffat, B.A.1
Chenevert, T.L.2
Lawrence, T.S.3
Meyer, C.R.4
Johnson, T.D.5
Dong, Q.6
Tsien, C.7
Mukherji, S.8
Quint, D.J.9
Gebarski, S.S.10
Robertson, P.L.11
Junck, L.R.12
Rehemtulla, A.13
Ross, B.D.14
-
21
-
-
49149113275
-
Functional diffusion map as an early imaging biomarker for high-grade glioma: Correlation with conventional radiologic response and overall survival
-
Hamstra DA, Galbán CJ, Meyer CR, Johnson TD, Sundgren PC, Tsien C, et al. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol 2008;26:3387-94.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3387-3394
-
-
Hamstra, D.A.1
Galbán, C.J.2
Meyer, C.R.3
Johnson, T.D.4
Sundgren, P.C.5
Tsien, C.6
-
22
-
-
0036525754
-
1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas
-
DOI 10.1016/S0360-3016(01)02769-9, PII S0360301601027699
-
Tarnawski R, Sokol M, Pieniazek P, Maciejewski B, Walecki J, Miszczyk L, et al. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malig-nant gliomas. Int J Radiat Oncol Biol Phys 2002;52:1271-6. (Pubitemid 34302880)
-
(2002)
International Journal of Radiation Oncology Biology Physics
, vol.52
, Issue.5
, pp. 1271-1276
-
-
Tarnawski, R.1
Sokol, M.2
Pieniazek, P.3
Maciejewski, B.4
Walecki, J.5
Miszczyk, L.6
Krupska, T.7
-
23
-
-
0035863501
-
Comparison of diameter and perimeter methods for tumor volume calculation
-
Sorensen AG, Patel S, Harmath C, Bridges S, Synnott J, Sievers A, et al. Comparision of diameter and perimeter methods for tumor volume calculation. J Clin Oncol 2001; 19:551-7 (Pubitemid 32112870)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.2
, pp. 551-557
-
-
Sorensen, A.G.1
Patel, S.2
Harmath, C.3
Bridges, S.4
Synnott, J.5
Sievers, A.6
Yoon, Y.-H.7
Lee, E.J.8
Yang, M.C.9
Lewis, R.F.10
Harris, G.J.11
Lev, M.12
Schaefer, P.W.13
Buchbinder, B.R.14
Barest, G.15
Yamada, K.16
Ponzo, J.17
Kwon, H.Y.18
Gemmete, J.19
Farkas, J.20
Tievsky, A.L.21
Ziegler, R.B.22
Salhus, M.R.C.23
Weisskoff, R.24
more..
-
24
-
-
33846955124
-
Early necrosis following recurrent temodar and radiotherapy in patients with glioblastoma
-
Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE. Early necrosis following recurrent temodar and radiotherapy in patients with glioblastoma. J Neurooncol 2007;82:81-3.
-
(2007)
J Neurooncol
, vol.82
, pp. 81-83
-
-
Chamberlain, M.C.1
Glantz, M.J.2
Chalmers, L.3
Van Horn, A.4
Sloan, A.E.5
-
25
-
-
42649106522
-
-
Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Lancet Oncol 2008;9:453-61.
-
(2008)
Lancet Oncol
, vol.9
, pp. 453-461
-
-
Brandsma, D.1
Stalpers, L.2
Taal, W.3
Sminia, P.4
Van Den Bent, M.J.5
-
26
-
-
20044372154
-
MGMT gene silencing and benefit from temozolomide in glioblastoma
-
DOI 10.1056/NEJMoa043331
-
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352: 997-1003. (Pubitemid 40349502)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.10
, pp. 997-1003
-
-
Hegi, M.E.1
Diserens, A.-C.2
Gorlia, T.3
Hamou, M.-F.4
De Tribolet, N.5
Weller, M.6
Kros, J.M.7
Hainfellner, J.A.8
Mason, W.9
Mariani, L.10
Bromberg, J.E.C.11
Hau, P.12
Mirimanoff, R.O.13
Cairncross, J.G.14
Janzer, R.C.15
Stupp, R.16
|